Security Improvements for Better and Safer Cross-Border ePrescription and Patient Summary Services

2017 ◽  
Vol 6 (1) ◽  
pp. 18-28 ◽  
Author(s):  
Dimitrios G. Katehakis ◽  
George Pangalos ◽  
Andriana Prentza

Large-scale deployment of electronic Prescription and Patient Summary services (eP/ PS) is expected to enable seamless cross-border care and secure access to patient health information between European healthcare systems. Guaranteeing national readiness to support priorities, determined at the political level, is also considered a key prerequisite for the facilitation of access to health services across borders. This work focuses on required technological improvements to address reliability and quality challenges through the adoption of generic/ non-health specific building blocks (BBs) for basic cross-border public services in Europe. More specifically, what is presented is the introduction of generic components for non-repudiation, end point detection, and electronic identification, to effectively support the implementation of Directive 2011/ 24 on the application of patients' rights in cross-border healthcare. These interventions are considered to be necessary steps for the introduction of better quality, trustworthy, cross-border eP/ PS across Europe.

Author(s):  
Dimitrios G. Katehakis ◽  
George Pangalos ◽  
Andriana Prentza

Preserving patient safety, patient rights, and safeguarding trust are crucial components for the provision of high-quality medical treatments across borders. This chapter focuses on required technological improvements to address quality challenges through the adoption of generic building blocks (BBs) towards enabling seamless care between European healthcare systems. The authors present important considerations that are relevant to incremental, cross-sectorial advancements for the enhancement of the technology used for the implementation of the directive on the application of patients' rights in cross-border healthcare. These include cross-domain technical BBs to support non-repudiation, capability lookup, dynamic service location, and electronic identification. The authors use cross-border electronic prescription and patient summary, as a case to discuss the use of related international interoperability standards, together with recommendations for future work relevant to the introduction of better quality, trustworthy, cross-border, electronic health services in Europe.


2016 ◽  
Vol 10 (3) ◽  
pp. 478-504 ◽  
Author(s):  
Dimitrios G. Katehakis ◽  
George Pangalos ◽  
Andriana Prentza

Purpose The purpose of the paper is to present a framework for moving cross-border ePrescription (eP) and Patient Summary (PS) services forward, bearing in mind the needs and requirements of the European e-health space for cross-border eP and PS services, the limitations of the already developed solutions, as well as outcomes available from other domains. Design/methodology/approach The outcomes of previous and current large-scale pilot projects, aiming toward the delivery of electronic cross-border services, are examined. Integration of generic building blocks (BBs) is considered for the further development of cross-border eP and PS, in line with the European Directive on patients’ rights in cross-border health care. Findings The e-health domain is expected to greatly benefit from mitigating non-domain concerns such as those for electronic identification, end point detection, non-repudiation and the use of electronic signatures and trust establishments for basic cross-border public services in Europe. Research limitations/implications Research limitations are related to the fact that electronic identification, electronic signature and semantic issues have not been fully addressed yet at a European level to support cross-border services. Practical implications Practical implications are related to the cooperation, European level compatibility and sustainability of the underlying national infrastructures required to support reliable and secure exchange of medical data, as well as the readiness to address continuously evolving interoperability, legal and security requirements in a cross-border setting. Originality/value The need for consolidating the existing outcomes of non-health specific BBs is examined for two high-priority e-health services. Ongoing progress is presented, together with related issues that need to be resolved for improving technical certainty and making it easier to use health-care services abroad in cases of emergency.


2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 591-591
Author(s):  
Tamar Wyte-Lake ◽  
Claudia Der-Martirosian ◽  
Aram Dobalian

Abstract Individuals aged seventy-five or older, who often present with multiple comorbidities and decreased functional status, typically prefer to age in their homes. Additionally, as in-home medical equipment evolves, more medically vulnerable individuals can receive care at home. Concomitantly, large-scale natural disasters disproportionally affect both the medically complex and the older old, two patient groups responsible for most medical surge after a disaster. To understand how to ameliorate this surge, we examined the activities of the nine US Department of Veterans Affairs Home-Based Primary Care programs during the 2017 Atlantic Hurricane Season. These and similar programs under Medicare connect the homebound to the healthcare community. Study findings support early implementation of preparedness procedures and intense post-Hurricane patient tracking as a means of limiting reductions in care and preventing significant disruptions to patient health. Engaging with home-based primary care programs during disasters is central to bolstering community resilience for these at-risk populations.


Talanta ◽  
2021 ◽  
Vol 224 ◽  
pp. 121735
Author(s):  
Claudio Avila ◽  
Christos Mantzaridis ◽  
Joan Ferré ◽  
Rodrigo Rocha de Oliveira ◽  
Uula Kantojärvi ◽  
...  

2021 ◽  
Vol 22 (11) ◽  
pp. 5793
Author(s):  
Brianna M. Quinville ◽  
Natalie M. Deschenes ◽  
Alex E. Ryckman ◽  
Jagdeep S. Walia

Sphingolipids are a specialized group of lipids essential to the composition of the plasma membrane of many cell types; however, they are primarily localized within the nervous system. The amphipathic properties of sphingolipids enable their participation in a variety of intricate metabolic pathways. Sphingoid bases are the building blocks for all sphingolipid derivatives, comprising a complex class of lipids. The biosynthesis and catabolism of these lipids play an integral role in small- and large-scale body functions, including participation in membrane domains and signalling; cell proliferation, death, migration, and invasiveness; inflammation; and central nervous system development. Recently, sphingolipids have become the focus of several fields of research in the medical and biological sciences, as these bioactive lipids have been identified as potent signalling and messenger molecules. Sphingolipids are now being exploited as therapeutic targets for several pathologies. Here we present a comprehensive review of the structure and metabolism of sphingolipids and their many functional roles within the cell. In addition, we highlight the role of sphingolipids in several pathologies, including inflammatory disease, cystic fibrosis, cancer, Alzheimer’s and Parkinson’s disease, and lysosomal storage disorders.


1979 ◽  
Vol 25 (6) ◽  
pp. 973-975 ◽  
Author(s):  
T Chard ◽  
A Sykes

Abstract We describe an immunoassay for human choriomammo-tropin by use of the fluorescein-labeled hormone (of human origin). The technique is generally similar to the radioimmunoassay for this material, but has the advantage of stability of tracer and avoidance of radiation hazard. However, the procedure requires approximately 50-fold more tracer than does the radioimmunoassay, and this would be a disadvantage with materials for which supplies of purified antigen are scarce. Furthermore, both within-assay variation (3.9%) and between-assay variation (7.8--7.9%) were less satisfactory than that of radioimmunoassay (1.5% and 2.2--3%, respectively). This is almost certainly the result of imprecision of end-point detection and could probably be corrected by further attention to equipment design.


2005 ◽  
Vol 38 (1) ◽  
pp. 115-120
Author(s):  
Hilario López García ◽  
Iván Machón González

1992 ◽  
Vol 191 (3-4) ◽  
pp. 525-529 ◽  
Author(s):  
R. Dolata ◽  
M. Fischer ◽  
W. Jutzi

Sign in / Sign up

Export Citation Format

Share Document